This enzyme mitigates the metabolic vulnerabilities associated with IDH mutations and IDH mutated glioma cells demonstrate increased sensitivity to glutaminase inhibition confirming the role of glutaminolysis as a key compensatory pathway in metabolic homoeostasis maintenance (Seltzer et al., 2010). Here, IDH1 is linked to central nervous system cancer.